Completed NA INTERVENTIONAL 3-arm NCT01581710

Response of FeNO, Small Airway Dysfunction and Lung Heterogeneity to 2-week Montelukast Treatment in Asthmatic Children.

A Double-blind, Randomized, Cross-over Design Study to Compare the Lung Function Measure of Montelukast Versus Placebo in Children With Mild Persistent Asthma

Sponsor: CHA University

Conditions Mild Persistent Asthma

Interventions Montelukast to placebo Placebo to montelukast

Updated 9 times since 2017 Last updated: Mar 14, 2018 Started: May 31, 2012 Primary completion: Sep 30, 2015 Completion: Dec 31, 2015

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT01581710, this NA trial focuses on Mild Persistent Asthma and remains completed. Sponsored by CHA University, it has been updated 9 times since 2012, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

9 versions recorded

Sep 2024 — Present [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Jan 2023 — Jul 2024 [monthly]

Completed NA
Dec 2022 — Jan 2023 [monthly]

Completed NA
Jun 2022 — Dec 2022 [monthly]

Completed NA

▶ Show 4 earlier versions

Jan 2021 — Jun 2022 [monthly]

Completed NA
Jun 2018 — Jan 2021 [monthly]

Completed NA
May 2018 — Jun 2018 [monthly]

Completed NA
Jan 2017 — May 2018 [monthly]

Completed NA

First recorded

May 2012

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

CHA University
Merck Sharp & Dohme LLC

Data source: CHA University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

No location information available.